Search
for
Sort by
Research 151–180 of 1000+
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- 6-Gingerol inhibits hair cycle via induction of MMP2 and MMP9 expression
- CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata
- Use of natural molecules as anti-angiogenic inhibitors for vascular endothelial growth factor receptor
- Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata
- 698 Effect of lithocholic acid as a ligand of vitamin D receptor on hair growth in alopecia
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Lichen Planopilaris
- Macrophages induce AKT/β-catenin-dependent Lgr5+ stem cell activation and hair follicle regeneration through TNF
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
- Therapeutic Effect of Rumex japonicus Houtt. on DNCB-Induced Atopic Dermatitis-Like Skin Lesions in Balb/c Mice and Human Keratinocyte HaCaT Cells
- Human Placenta Extract (HPH) Suppresses Inflammatory Responses in TNF-α/IFN-γ-Stimulated HaCaT Cells and a DNCB Atopic Dermatitis (AD)-Like Mouse Model
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Efficacy of tofacitinib in pediatric alopecia universalis
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- Oncogenes and morphogens: intricacies of targeted therapy in cutaneous basal cell carcinoma
- General Dermatology
- Management of congenital ichthyoses: European guidelines of care, part two